CellPrint’s proprietary CellPrint™ technology platform provides unparalleled resolution of lineage-specific molecular expression by cells circulating in peripheral blood.

Our scientists apply the technology to generate new-to-the-world knowledge about pathogenesis, molecular targets for pharmaceutical agents, and biomarkers for predicting and measuring clinical outcomes.

We partner with pharmaceutical companies and researchers that recognize the platform’s transformational capability to advance drug discovery and development in diverse therapeutic areas, from oncology to neuro-psychiatry.